02:04 PM EDT, 09/25/2024 (MT Newswires) -- Health care stocks dropped Wednesday afternoon with the NYSE Health Care Index down 0.5% and the Health Care Select Sector SPDR Fund (XLV) shedding 0.8%.

The iShares Biotechnology ETF (IBB) fell 1.3%.

In corporate news, Biogen (BIIB) was sued by the city of Baltimore for allegedly engaging in an "unlawful scheme" to reduce competition from generic versions of its brand-name drug Tecfidera for multiple sclerosis. The shares fell 2%.

CERo Therapeutics ( CERO ) shares jumped 11% after Chief Executive Officer Brian Atwood, Chief Financial Officer Charles Carter and Chief Technology Officer Daniel Corey stepped down.

HeartCore Enterprises ( HTCR ) shares rose 4.9% after the company posted Q3 revenue guidance of $19 million to $23 million.